Objective. There is some evidence implicating receptor for advanced glycation end products ( RAGE) signaling in the pathogenesis of neuropathic pain (NP). The objective was to investigate whether RAGE signaling in the dorsal root ganglion ( DRG) might contribute to NP following peripheral nerve injury. Design. Experimental study before and after spinal nerve ligation (SNL) surgery. Setting. Caged in a controlled environment. Subjects. Male Sprague-Dawley rats. Methods. A SNL rat model of NP was used. Mechanical hyperalgesia was measured by the paw withdrawal threshold (PWT) to mechanical stimuli (1.4-15 g). Protein expressions of RAGE (immunofluorescence and western blotting), glial fibrillary acidic protein (GFAP; satellite glial cell [SGC] activation marker), IL-1 beta (ELISA), TNF-alpha (ELISA), and NF-kappa B (western blotting) in the DRG were determined. RAGE signaling was inhibited by intrathecal injection of anti-RAGE antibody. Results. After 7 days, SNL surgery reduced the PWT and upregulated the protein expression of RAGE, GFAP, NF-kappa B, TNF-alpha, and IL-1 beta. Intrathecal injection of RAGE-neutralizing antibody attenuated the SNL-induced mechanical hyperalgesia, activation of SGCs, and upregulation of NF-kappa B, TNF-alpha, and IL-1 beta in the DRG. Conclusion. RAGE signaling may contribute to the pain hypersensitivity observed in the rat SNL model of NP. Although the precise mechanism remains to be established, NF-kappa B, TNF-alpha, and IL-1 beta likely play a role, together with the activation of SGCs.